硬膜外镇痛与结直肠癌术后复发:丹麦回顾性登记队列研究
该研究基于丹麦结直肠癌组数据库和丹麦麻醉数据库,纳入2004至2018年间无残留肿瘤的结直肠癌手术患者,采用倾向性评分匹配调整术前混杂因素,比较术前置入硬膜外导管镇痛与未置入者的复发和死亡风险。匹配队列每组2980例,中位随访58个月,硬膜外镇痛组复发567例(19.0%),无硬膜外组610例(20.5%),复发风险比0.91(95%CI 0.82-1.02),死亡风险比1.01(95%CI 0.92-1.10),均无统计学显著关联。
要点
- 硬膜外镇痛与结直肠癌复发风险比0.91(95%CI 0.82-1.02),无统计学显著关联。
- 硬膜外镇痛与死亡风险比1.01(95%CI 0.92-1.10),无统计学显著关联。
- 倾向性评分匹配后每组2980例,中位随访58个月。
核心结论
- 在结直肠癌手术中,硬膜外镇痛与较少的癌症复发无统计学显著关联。
研究设计与样本
- 丹麦回顾性登记队列研究,使用丹麦结直肠癌组数据库和丹麦麻醉数据库识别2004至2018年间无残留肿瘤的结直肠癌手术患者。
- 研究人群11618例,其中3496例(30.1%)术前置入硬膜外导管;采用倾向性评分匹配调整术前混杂因素。
- 匹配队列每组2980例,中位随访58个月(四分位距29至86)。
主要发现
- 硬膜外镇痛组复发567例(19.0%),无硬膜外镇痛组复发610例(20.5%)。
- 硬膜外镇痛与复发风险比0.91(95%CI 0.82-1.02),无统计学显著关联。
- 硬膜外镇痛与死亡风险比1.01(95%CI 0.92-1.10),无统计学显著关联。
临床怎么用
- 对于结直肠癌手术患者,硬膜外镇痛不应以降低癌症复发风险为主要目的进行选择。
局限性
- 本研究为回顾性登记队列研究,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgery is the main curative treatment for colorectal cancer. Yet the immunologic and humoral response to surgery may facilitate progression of micro-metastases. It has been suggested that epidural analgesia preserves immune competency and prevents metastasis formation. Hence, the authors tested the hypothesis that epidural analgesia would result in less cancer recurrence after colorectal cancer surgery. METHODS: The Danish Colorectal Cancer Group Database and the Danish Anesthesia Database were used to identify patients operated for colorectal cancer between 2004 and 2018 with no residual tumor tissue left after surgery. The exposure group was defined by preoperative insertion of an epidural catheter for analgesia. The primary outcome was colorectal cancer recurrence, and the secondary outcome was mortality. Recurrences were identified using a validated algorithm based on data from Danish health registries. Follow-up was until death or September 7, 2018. The authors used propensity score matching to adjust for potential preoperative confounders. RESULTS: In the study population of 11,618 individuals, 3,496 (30.1%) had an epidural catheter inserted before surgery. The epidural analgesia group had higher proportions of total IV anesthesia, laparotomies, and rectal tumors, and epidural analgesia was most frequently used between 2009 and 2012. The propensity score-matched study cohort consisted of 2,980 individuals in each group with balanced baseline covariates. Median follow-up was 58 months (interquartile range, 29 to 86). Recurrence occurred in 567 (19.0%) individuals in the epidural analgesia group and 610 (20.5%) in the group without epidural analgesia. The authors found no association between epidural analgesia and recurrence (hazard ratio, 0.91; 95% CI, 0.82 to 1.02) or mortality (hazard ratio, 1.01; 95% CI, 0.92 to 1.10). CONCLUSIONS: In colorectal cancer surgery, epidural analgesia was not statistically significantly associated with less cancer recurrence.
引用
- Hasselager RP, Hallas J, Gögenur I, et al. Epidural Analgesia and Recurrence after Colorectal Cancer Surgery: A Danish Retrospective Registry-based Cohort Study. Anesthesiology. 2022. PMID: 35045154. doi:10.1097/ALN.0000000000004132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。